The proposal continues our objective to elucidate the molecular events that control acute systemic inflammation, a highly lethal process. In the previous grant cycle, we discovered a Toll like receptor (TLR) - driven, temportally-defined, epigenetic program in innate immunity macrophages and neutrophis, which directs the course of acute systemic inflammation. This process modifies chromatin structure to repress or activate distinct functional sets of genes, thus generating distinct phenotypic phases. Others and we have shown that bioenergy shifts also occur in innate immunity cells during acute systemic inflammation. This application develops the unified concept that modifications in bioenergetics integrate with epigenetics to direct the phase shifts of acute inflammation. We propose two specific aims:
Aim 1) To define the connections between bio-energy and epigenetics. We will use a cell model that reproduces TLR4-dependent phase shifts to: a) delineate gene-specific chromatin modifications;b) determine protein-protein interactions;c) assess metabolic profiles by mass spectroscopy;and c) translate our concept to human normal and sepsis blood leukocytes.
Aim 2) To test effects of modifying bio-energy and epigenetic shift on clinical outcomes. We will us a murine model of sepsis to: a) define bio-energy and epigenetic phase shifts, using biochemical and genetic methods to analyze plasma and isolated leukocytes from spleen, peritoneum, and bone marrow;and b) use pharmacologic and genetic approaches to determine whether modifying to adaptive phase alters microvascular inflammation and survival. Our result will broadly impact the field of inflammation by providing new insight on how acute inflammation is orchestrated, and inform novel therapies.
Acute systemic inflammation is a major health care problem, killing ~300,000/ yr in USA. No effective therapies exist for altering the inflammatory component of the disease. This research will provide new insight into the molecular events that coordinate the temporal features of sepsis, and enable design of therapies.
|Long, David; Wu, Hanzhi; Tsang, Allen W et al. (2017) The Oxidative State of Cysteine Thiol 144 Regulates the SIRT6 Glucose Homeostat. Sci Rep 7:11005|
|Buechler, Nancy; Wang, Xianfeng; Yoza, Barbara K et al. (2017) Sirtuin 2 Regulates Microvascular Inflammation during Sepsis. J Immunol Res 2017:2648946|
|Wang, Xianfeng; Buechler, Nancy L; Martin, Ayana et al. (2016) Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice. PLoS One 11:e0160431|
|Wang, XianFeng; Buechler, Nancy L; Yoza, Barbara K et al. (2016) Adiponectin treatment attenuates inflammatory response during early sepsis in obese mice. J Inflamm Res 9:167-174|
|Vachharajani, Vidula T; Liu, Tiefu; Wang, Xianfeng et al. (2016) Sirtuins Link Inflammation and Metabolism. J Immunol Res 2016:8167273|
|Millet, Patrick; Vachharajani, Vidula; McPhail, Linda et al. (2016) GAPDH Binding to TNF-? mRNA Contributes to Posttranscriptional Repression in Monocytes: A Novel Mechanism of Communication between Inflammation and Metabolism. J Immunol 196:2541-51|
|Ding, Jingzhong; Reynolds, Lindsay M; Zeller, Tanja et al. (2015) Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease. Diabetes 64:3464-74|
|Wang, Xianfeng; Buechler, Nancy L; Yoza, Barbara K et al. (2015) Resveratrol attenuates microvascular inflammation in sepsis via SIRT-1-Induced modulation of adhesion molecules in ob/ob mice. Obesity (Silver Spring) 23:1209-17|
|Smith, Lane M; Wells, Jonathan D; Vachharajani, Vidula T et al. (2015) SIRT1 mediates a primed response to immune challenge after traumatic lung injury. J Trauma Acute Care Surg 78:1034-8|
|Reynolds, Lindsay M; Ding, Jingzhong; Taylor, Jackson R et al. (2015) Transcriptomic profiles of aging in purified human immune cells. BMC Genomics 16:333|
Showing the most recent 10 out of 43 publications